Akebia Therapeutics, Inc is a biotechnology business based in the US. Akebia Therapeutics shares (AKBA) are listed on the NASDAQ and all prices are listed in US Dollars. Akebia Therapeutics employs 379 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Akebia Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AKBA – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Akebia Therapeutics stock price (NASDAQ: AKBA)Use our graph to track the performance of AKBA stocks over time.
Akebia Therapeutics shares at a glance
|Latest market close||$3.51|
|52-week range||$2.09 - $12.48|
|50-day moving average||$3.54|
|200-day moving average||$3.46|
|Wall St. target price||$6.57|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.40|
Buy Akebia Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akebia Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Akebia Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-13.97%|
|3 months (2021-04-28)||9.69%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Akebia Therapeutics financials
|Revenue TTM||$259.1 million|
|Gross profit TTM||$12.9 million|
|Return on assets TTM||-14.83%|
|Return on equity TTM||-128.57%|
|Market capitalisation||$432.3 million|
TTM: trailing 12 months
Shorting Akebia Therapeutics shares
There are currently 15.3 million Akebia Therapeutics shares held short by investors – that's known as Akebia Therapeutics's "short interest". This figure is 2.2% down from 15.6 million last month.
There are a few different ways that this level of interest in shorting Akebia Therapeutics shares can be evaluated.
Akebia Therapeutics's "short interest ratio" (SIR)
Akebia Therapeutics's "short interest ratio" (SIR) is the quantity of Akebia Therapeutics shares currently shorted divided by the average quantity of Akebia Therapeutics shares traded daily (recently around 4.2 million). Akebia Therapeutics's SIR currently stands at 3.61. In other words for every 100,000 Akebia Therapeutics shares traded daily on the market, roughly 3610 shares are currently held short.
However Akebia Therapeutics's short interest can also be evaluated against the total number of Akebia Therapeutics shares, or, against the total number of tradable Akebia Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akebia Therapeutics's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Akebia Therapeutics shares in existence, roughly 100 shares are currently held short) or 0.0963% of the tradable shares (for every 100,000 tradable Akebia Therapeutics shares, roughly 96 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Akebia Therapeutics.
Find out more about how you can short Akebia Therapeutics stock.
Akebia Therapeutics share dividends
We're not expecting Akebia Therapeutics to pay a dividend over the next 12 months.
Akebia Therapeutics share price volatility
Over the last 12 months, Akebia Therapeutics's shares have ranged in value from as little as $2.09 up to $12.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akebia Therapeutics's is 1.7437. This would suggest that Akebia Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Akebia Therapeutics overview
Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of renal therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd.
Stocks similar to Akebia Therapeutics
Akebia Therapeutics in the news
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akebia Therapeutics, Inc. and Encourages Investors who Formerly Held Shares of Keryx Biopharmaceuticals (KERX) to Contact the Firm
SHAREHOLDER ALERT: Robbins LLP Announces that Akebia Therapeutics, Inc. (AKBA) is Being Sued for Misleading Keryx Biopharmaceuticals, Inc. (KERX) Shareholders Ahead of Merger
Akebia Therapeutics to Report Second Quarter 2021 Financial Results and Discuss Recent Business Highlights
Frequently asked questionsWhat percentage of Akebia Therapeutics is owned by insiders or institutions?
Currently 1.137% of Akebia Therapeutics shares are held by insiders and 64.728% by institutions. How many people work for Akebia Therapeutics?
Latest data suggests 379 work at Akebia Therapeutics. When does the fiscal year end for Akebia Therapeutics?
Akebia Therapeutics's fiscal year ends in December. Where is Akebia Therapeutics based?
Akebia Therapeutics's address is: 245 First Street, Cambridge, MA, United States, 02142 What is Akebia Therapeutics's ISIN number?
Akebia Therapeutics's international securities identification number is: US00972D1054 What is Akebia Therapeutics's CUSIP number?
Akebia Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00972D105
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert